Department of Human Biology, Maastricht University Medical Centre +, PO Box 616, 6200 MD Maastricht, The Netherlands.
Obes Rev. 2011 Jun;12(6):470-7. doi: 10.1111/j.1467-789X.2010.00788.x. Epub 2010 Sep 6.
This review discusses the role of enteroendocrine cells in the gastrointestinal tract as chemoreceptors that sense intraluminal contents and induce changes in food intake through the release of signalling substances, such as satiety hormones. Recent evidence supports the concept that chemosensing in the gut involves G protein-coupled receptors (GPCRs) that are known to mediate gustatory signals in the oral cavity. GPCRs can be grouped into several families, depending on the stimuli to which they respond, e.g. proteins, amino acids, carbohydrates, fatty acids, or tastants. Sensing of these stimuli by GPCRs results in hormone secretions of enteroendocrine cells, which participate in the control of food intake. A better understanding of the stimuli that induce the strongest binding with these receptors, and thus induce a strong release of hormones, can be a very useful strategy for the development of novel foods in the treatment of obesity.
这篇综述讨论了肠内分泌细胞作为化学感受器在胃肠道中的作用,这些细胞可以感知腔内内容物,并通过释放信号物质(如饱腹感激素)来诱导食物摄入的变化。最近的证据支持这样一种观点,即肠道中的化学感应涉及 G 蛋白偶联受体(GPCR),这些受体已知在口腔中介导味觉信号。GPCR 可以根据它们所响应的刺激物分为几个家族,例如蛋白质、氨基酸、碳水化合物、脂肪酸或味觉物质。GPCR 对这些刺激物的感应导致肠内分泌细胞分泌激素,这些激素参与食物摄入的控制。更好地了解哪些刺激物与这些受体结合最强,并因此强烈释放激素,这可能是开发用于治疗肥胖症的新型食品的非常有用的策略。